• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.49 Down 0.02(1.32%) Apr 24, 4:02PM EDT
    Add to Portfolio
    Prev Close:1.51
    Open:1.50
    Bid:1.49 x 3100
    Ask:1.50 x 9400
    1y Target Est:4.56
    Beta:1.04
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:1.49 - 1.53
    52wk Range:0.97 - 2.02
    Volume:291,349
    Avg Vol (3m):519,667
    Market Cap:224.00M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 1.32%224.00M
    LLYDown 1.13%75.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):36.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.13
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback